ADC Therapeutics (ADCT) Operating Income (QoQ) (2020 - 2025)

ADC Therapeutics (ADCT) Operating Income (QoQ) (2020 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 ADC Therapeutics 189.60 Mn -41.41 Mn 17.38 Mn

Historic Data

Download Data
DateValue
Sep 30, 2025 29.85%
Jun 30, 2025 -55.10%
Sep 30, 2024 -22.46%
Jun 30, 2024 13.60%
Sep 30, 2023 8.83%
Jun 30, 2023 23.12%
Sep 30, 2022 95.51%
Jun 30, 2022 -71.96%
Sep 30, 2021 18.00%
Jun 30, 2021 0.26%
Sep 30, 2020 -16.64%
Jun 30, 2020 -2.42%